Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Wendy Mao, Ali Ghasemzadeh, Zachary T. Freeman, Aleksandar Obradovic, Matthew G. Chaimowitz, Thomas R. Nirschl, Emily McKiernan, Srinivasan Yegnasubramanian, Charles G. Drake
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 277; DOI: 10.1186/s40425-019-0758-y